Gabapentin
Product Images NDC 55695-016

6 FDA label images from Department Of State Health Services, Pharmacy Branch · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 55695-016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Department Of State Health Services, Pharmacy Branch, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label1 (Label1)

Label1 (Label1)
Prescription label from City of Houston Pharmacy Commerce for Gabapentin capsules 100 mg, quantity 100. The label includes patient instructions in English and Spanish, a barcode, and expiration date of 02/28/2016. Labeler is Department of State Health Services, Pharmacy Branch.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph showing the mean pain score over eight weeks comparing placebo and Gabapentin 3600 mg/day. The graph marks a 4-week dose titration period followed by a 4-week fixed dose period, with Gabapentin demonstrating a decline in mean pain score compared to the placebo group over time.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line graph showing the mean pain score over weeks during a 3-week dose titration period and a 4-week fixed dose period. It compares placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day groups, with pain scores decreasing more in the gabapentin groups over time.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A bar chart depicting the percentage of responders at the endpoint for two studies comparing placebo (PBO) and Gabapentin (GBP) at different dosages. Study 1 shows PBO at 12% and GBP 3600 mg at 29%, while Study 2 shows PBO at 14%, GBP 1800 mg at 32%, and GBP 2400 mg at 34%, with statistical significance indicated for higher GBP groups.*
FDA Label Image

Figure4 (Figure4)

Figure4 (Figure4)
A scatter plot chart showing the percentage difference on the y-axis versus daily dose in milligrams on the x-axis for Gabapentin. The chart displays data from three studies labeled as Study a, Study b, and Study c, each represented by distinct markers at doses of 600, 900, 1200, and 1800 mg.*
FDA Label Image

Gabapentin-struc (Gabapentin Struc)

Gabapentin-struc (Gabapentin Struc)
Chemical structure diagram of Gabapentin showing its molecular configuration with a cyclohexane ring and amino and carboxyl side groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.